We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In addition to its pact with GSK, CureVac has also partnered with Novartis and Bayer to potentially manufacture hundreds of millions of doses of CVnCoV. Read More
The Biden administration announced Friday that it is dedicating $1.7 billion in funding from the COVID-19 relief package to ramp up U.S. capabilities for genomic sequencing, an effort to improve the ability of the Centers for Disease Control and Prevention (CDC) and the nation’s health departments to detect potentially deadly mutations. Read More
The Centers for Disease Control and Prevention (CDC) will convene a second emergency meeting of its Advisory Committee on Immunization Practices at the end of the week to discuss the use of Johnson & Johnson (J&J)’s COVID-19 vaccine, following a delayed vote at its initial discussion on cases of very rare blood clots seen in vaccinated patients. Read More
Novartis has agreed to help manufacture Roche’s blockbuster rheumatoid arthritis drug Actemra (tocilizumab) as a COVID-19 treatment — in another pact that offers the company’s manufacturing might to help produce a rival’s COVID-19 therapies or vaccines. Read More
Merck has decided to end research and development on MK-7110, an experimental oral drug for treatment of hospitalized coronavirus patients that had shown promise in a late-stage trial. Read More
People vaccinated with Pfizer/BioNTech’s double-dose COVID-19 vaccine will likely need to receive a booster shot within a year of full inoculation, as well as an annual shot, according to Pfizer CEO Albert Bourla. Read More
Pfizer has accelerated COVID-19 vaccine production and is on track to distribute 300 million doses in the U.S. before the end of July, said the company’s CEO Albert Bourla. Read More
Rumors are circulating in Europe that the European Commission (EC) will decline to renew its COVID-19 vaccine contracts with AstraZeneca (AZ) and Johnson & Johnson (J&J) once they expire, and a commission spokesperson has given a less-than ringing endorsement of the vaccines. Read More